QDEL:NASDAQ
Quidelortho Corp
$10.82
arrow_upward
+0.46%(+0.050) 1D
Oct 5, 9:33:01 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$10.86
High
$10.88
Low
$10.52
Mkt. cap
741.99M
Avg. vol.
1.42M
Volume
973.00
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
Open
$10.86
High
$10.88
Low
$10.52
Mkt. cap
741.99M
Avg. vol.
1.42M
Volume
973.00
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
News stories
From web sources and news partners
TradingView
·
23 minutes ago
Voyager Awarded $22.4M Dow Contract For Next-Gen Satellite Deployment Systems
BNN Bloomberg
·
31 minutes ago
U.S. futures edge lower under sustained pressure from bond markets
marketscreener.com
·
31 minutes ago
ROI-Wall Street bulls try on 'S&P 10,000' caps for size: McGeever
Altcoin Buzz
·
1 hour ago
Kalshi Gets CFTC Approval for S&P 500 Perpetual Futures
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorMedical device
Websitequidelortho.com